These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10511398)

  • 21. Pharmacokinetics and burn eschar penetration of intravenous ciprofloxacin in patients with major thermal injuries.
    Varela JE; Cohn SM; Brown M; Ward CG; Namias N; Spalding PB
    J Antimicrob Chemother; 2000 Mar; 45(3):337-42. PubMed ID: 10702553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibiotics, developments and orientation].
    de Marie S; Verbrugh HA
    Ned Tijdschr Geneeskd; 1992 Apr; 136(14):673-8. PubMed ID: 1560853
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.
    Touw DJ; Vinks AA; Mouton JW; Horrevorts AM
    Clin Pharmacokinet; 1998 Dec; 35(6):437-59. PubMed ID: 9884816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients.
    Pruskowski KA
    Surg Infect (Larchmt); 2021 Feb; 22(1):77-82. PubMed ID: 33164665
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased amikacin dosage requirements in burn patients receiving a once-daily regimen.
    Conil JM; Georges B; Breden A; Segonds C; Lavit M; Seguin T; Coley N; Samii K; Chabanon G; Houin G; Saivin S
    Int J Antimicrob Agents; 2006 Sep; 28(3):226-30. PubMed ID: 16908121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics in patients with burns.
    Jaehde U; Sörgel F
    Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug kinetics in burn patients.
    Sawchuk RJ; Rector TS
    Clin Pharmacokinet; 1980; 5(6):548-56. PubMed ID: 7002419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing initial vancomycin dosing in burn patients.
    Elligsen M; Walker SA; Walker SE; Simor A
    Burns; 2011 May; 37(3):406-14. PubMed ID: 21095062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology and pharmacokinetics following burn injury.
    Bonate PL
    Clin Pharmacokinet; 1990 Feb; 18(2):118-30. PubMed ID: 2180612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.
    Bearden DT; Rodvold KA
    Clin Pharmacokinet; 2000 May; 38(5):415-26. PubMed ID: 10843460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftazidime dosage recommendations in burn patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations.
    Conil JM; Georges B; Ravat F; Ruiz S; Seguin T; Metsu D; Fourcade O; Saivin S
    Clin Ther; 2013 Oct; 35(10):1603-12. PubMed ID: 24094465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.
    Schentag JJ
    J Chemother; 1999 Dec; 11(6):426-39. PubMed ID: 10678784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraphagocytic penetration of antibiotics.
    Van der Auwera P; Matsumoto T; Husson M
    J Antimicrob Chemother; 1988 Aug; 22(2):185-92. PubMed ID: 2846489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New antibiotics: carbapenems, monobactams and quinolones.
    Amin NM
    Am Fam Physician; 1988 Oct; 38(4):125-34. PubMed ID: 3051970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of aminoglycosides in patients with chronic spinal cord injury.
    Young F; Ensom MH
    Am J Health Syst Pharm; 2011 Sep; 68(17):1607-14. PubMed ID: 21856806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of antibacterial drugs in neonates.
    Paap CM; Nahata MC
    Clin Pharmacokinet; 1990 Oct; 19(4):280-318. PubMed ID: 2208898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An updated comparison of drug dosing methods. Part III: Aminoglycoside antibiotics.
    Erdman SM; Rodvold KA; Pryka RD
    Clin Pharmacokinet; 1991 May; 20(5):374-88. PubMed ID: 1908755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.